06/01/2026
The future of Rare Disease innovation will be shaped through stronger collaboration, smarter technology, and more connected healthcare ecosystems. ๐
Jeeva Clinical Trials is excited to share that Harsha Rajasimha, our Founder & CEO, will be attending World Orphan Drug Congress USA 2026, one of the leading global events bringing together leaders across biotech, healthcare, research, and patient advocacy.
๐
June 9โ11, 2026
๐ Boston, MA, USA
The event offers an opportunity to engage in important conversations around rare disease innovation, clinical research, patient engagement, and the future of therapeutic development.
We look forward to engaging with industry leaders and contributing perspectives on modernizing clinical research infrastructure.
๐ Register here: https://hubs.la/Q04jrZyG0
๐ Learn more about Jeeva Clinical Trials: https://hubs.la/Q04jxj060